Multi-center study for efficacy of TAZ/PIPC on catheter-associated urinary tract infection (CAUTI)
Not Applicable
- Conditions
- Catheter-associated urinary tract infection
- Registration Number
- JPRN-UMIN000032200
- Lead Sponsor
- Kobe University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Those patients with allergy for TAZ/PIPC. Those patients with the previous UTI whiose causative bacteria showed TAZ/PIPC-resistance.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TAZ/PIPC 13.5g/day treatment on CAUTI will be done for 1 week and 1st outcome evaluation will be don, then antibiotics will be switched to oral one by de-escalation for another a week. Then, 2nd outcome evaluation will be done. Then, after 1 week of no-administration of antibiotics, 3rd outcome evaluation will be undertaken.Basically outcome evaluation is done by symptom of infectious diseases.
- Secondary Outcome Measures
Name Time Method